OA
LLY icon

Oxbow Advisors’s Eli Lilly LLY Stock Holding History

Oxbow Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-727
Closed -$566K – 225
2025
Q2 		$566K Sell
727
-218
-23% -$169K 0.06% 132
2025
Q1 		$781K Hold
945
– – 0.08% 121
2024
Q4 		$730K Sell
945
-147
-13% -$122K 0.09% 121
2024
Q3 		$967K Buy
1,092
+46
+4% +$41.4K 0.1% 110
2024
Q2 		$947K Buy
1,046
+25
+2% +$20K 0.11% 101
2024
Q1 		$794K Sell
1,021
-243
-19% -$173K 0.11% 99
2023
Q4 		$737K Buy
1,264
+1
+0.1% +$584 0.11% 104
2023
Q3 		$679K Buy
1,263
+418
+49% +$215K 0.11% 101
2023
Q2 		$396K Buy
845
+52
+7% +$21.8K 0.06% 144
2023
Q1 		$272K Hold
793
– – 0.05% 172
2022
Q4 		$290K Hold
793
– – 0.05% 168
2022
Q3 		$256K Buy
+793
New +$251K 0.04% 206
2022
Q1 		– Sell
-975
Closed -$269K – 275
2021
Q4 		$269K Hold
975
– – 0.03% 243
2021
Q3 		$225K Hold
975
– – 0.02% 260
2021
Q2 		$224K Sell
975
-110
-10% -$22.1K 0.02% 266
2021
Q1 		$203K Buy
+1,085
New +$212K 0.02% 270
2020
Q2 		– Sell
-1,883
Closed -$261K – 282
2020
Q1 		$261K Hold
1,883
– – 0.04% 226
2019
Q4 		$248K Buy
+1,883
New +$218K 0.03% 252
2018
Q2 		– Sell
-5,326
Closed -$412K – 305
2018
Q1 		$412K Sell
5,326
-110
-2% -$8.86K 0.08% 168
2017
Q4 		$459K Buy
5,436
+113
+2% +$9.62K 0.09% 174
2017
Q3 		$455K Sell
5,323
-4,999
-48% -$410K 0.09% 163
2017
Q2 		$850K Buy
+10,322
New +$842K 0.15% 140

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Oxbow Advisors's LLY Position: Q3 2025 in Review

Oxbow Advisors sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 727 shares — an estimated $566K sold.

Oxbow Advisors first reported a position in LLY in Q2 2017 and held it in 22 quarters. The position peaked at $967K in Q3 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Oxbow Advisors reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Oxbow Advisors sold 727 Eli Lilly shares in Q3 2025, an estimated $566K.
  • Oxbow Advisors first reported a position in Eli Lilly in Q2 2017 and held it in 22 quarters.
  • Oxbow Advisors's Eli Lilly position peaked at $967K in Q3 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Oxbow Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.